Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-induction hypotension with general anesthesia: remimazolam versus propofol
KCT0006573Phase 4Recruiting
- Sponsor
- Hana Pharm
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam, propofol in hypotension, sponsored by Hana Pharm. Started Dec 2021; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
hypotension
Beyond the preview
Go deeper on KCT0006573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006573.